Notices. Notice of application
299 words·~1 min read·
/register/2021/09/13/2021-19679A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4410-09-P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-899] Bulk Manufacturer of Controlled Substances Application: Eli-Elsohly Laboratories AGENCY: Drug Enforcement Administration, Justice. ACTION: Notice of application. SUMMARY: Eli-Elsohly Laboratories has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before November 12, 2021.
Such persons may also file a written request for a hearing on the application on or before November 12, 2021. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on August 5, 2021, Eli-Elsohly Laboratories, 5 Industrial Park Drive, Oxford, Mississippi 38655, applied to be registered as an bulk manufacturer of the following basic class(es) of controlled substance(s):
Controlled substances Drug code Schedule Marihuana Extract 7350 I Marihuana 7360 I Tetrahydrocannabinols 7370 I Amphetamine 1100 II Methamphetamine 1105 II Cocaine 9041 II Codeine 9050 II Dihydrocodeine 9120 II Ecgonine 9180 II Thebaine 9333 II The company plans to manufacture the listed controlled substances for product development and reference standards. In reference to drug codes 7360 (Marihuana) and 7370 (Tetrahydrocannabinols), the company plans to isolate these controlled substances from procured 7350 (Marihuana Extract).
In reference to drug code 7360, no cultivation activities are authorized for this registration. In reference to drug code 9333 (Thebaine), the company plans to manufacture a Thebaine derivative. No other activities for these drug codes are authorized for this registration. Brian S. Bresser, Acting Assistant Administrator. [FR Doc. 2021-19679 Filed 9-10-21; 8:45 am]
Connectionstraces to 1
Traces to 1 document
Citation graph
cites case law
Notices
Notice of application
Cites 1Cited by 0 across 0 sources